Xpert Xpress SARS-CoV-2 Test

News Releases

Month Year

Month Year

Feb 3, 2016

Cepheid to Webcast Upcoming Financial Presentations
Feb 2, 2016

Cepheid Reports Fourth Quarter And Full Year 2015 Results

Commercial Clinical Grew 19%, or 21% in Constant Currency, Driven by Record Reagent Revenue and Record GeneXpert System Placements
Jan 13, 2016

Cepheid Announces Diagnostic Collaboration With MedImmune And COMBACTE To Facilitate Clinical Trials Of New Monoclonal Antibodies To Prevent Serious Infectious Diseases

GeneXpert Systems and Xpert Tests Expected to Enhance Efficiency of Clinical Trials
Jan 11, 2016

Cepheid Schedules 2015 Fourth Quarter And Full Year Results Announcement And Webcast

Announces Preliminary Q415 Revenue of Approximately $147 Million
Jan 7, 2016

USAID And Cepheid Plan Collaboration To Accelerate Global Diagnosis Of Multidrug-Resistant Tuberculosis
Jan 5, 2016

Cepheid to Webcast Upcoming Financial Presentations
Jan 4, 2016

Cepheid Announces Distribution Agreement with Henry Schein
Dec 8, 2015

Cepheid Announces International Commercial Availability Of Next Generation BCR-ABL Test

Xpert BCR-ABL Ultra Assesses Deep Molecular Response in Chronic Myeloid Leukemia Patients on Treatment with Tyrosine Kinase Inhibitors
Dec 7, 2015

Cepheid Receives FDA CLIA Waiver for Xpert Flu+RSV Xpress Test

Reference Laboratory Test Performance at the Point of Care
Dec 3, 2015

FIND And Cepheid Announce A Strategic Collaboration To Advance Point-Of-Care TB Diagnosis

Show per page

Back to Top